These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS. Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707 [Abstract] [Full Text] [Related]
3. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [Abstract] [Full Text] [Related]
4. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H. J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812 [Abstract] [Full Text] [Related]
8. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH. Nucl Med Commun; 2013 Oct; 34(10):959-63. PubMed ID: 23921784 [Abstract] [Full Text] [Related]
9. Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET/CT in Patients with Colorectal Cancer. Ogawa S, Itabashi M, Kondo C, Momose M, Sakai S, Kameoka S. Anticancer Res; 2015 Jun; 35(6):3495-500. PubMed ID: 26026116 [Abstract] [Full Text] [Related]
10. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer. Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY. J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185 [Abstract] [Full Text] [Related]
11. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ. Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [Abstract] [Full Text] [Related]
16. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer. Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H. Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127 [Abstract] [Full Text] [Related]
18. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS, Kim JS, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY. Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [Abstract] [Full Text] [Related]
19. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma. Kim YI, Kim SK, Paeng JC, Lee HY. Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142 [Abstract] [Full Text] [Related]